1. Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy. (2nd November 2019) Authors: Mittal, Deepak; Vijayan, Dipti; Neijssen, Joost; Kreijtz, Joost; Habraken, Maurice M. J. M.; Van Eenennaam, Hans; Van Elsas, Andrea; Smyth, Mark J. Journal: Oncoimmunology Issue: Volume 8:Number 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗